Please Wait
Applying Filters...
menu
    • menu
    Athena Pharmaceutiques is a Partner of Choice for Drug Delivery & Life Cycle Management.

    Virtual Booth

    Contact Supplier

    Kikkoman Biochemifa Company advances global health and safety through precision-driven innovation in biotech and food testing.

    Virtual Booth

    Contact Supplier

    Rusan Pharma: Over 30 years of specializing in the treatment of Addiction and Pain Management.

    Virtual Booth

    Contact Supplier

    TransoPharm USA works in the Sourcing and Management of Active Pharmaceutical Ingredients.

    Virtual Booth

    Contact Supplier

    Moehs Group, a reference company in the production of pharmaceutical active ingredients.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-10-20

    Virtual Booth

    An Enquiry

    Menu

    Axitinib

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 453,502Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    HUTCHMED to Present FRUSICA-2 Trial Data at ESMO 2025
    HUTCHMED to Present FRUSICA-2 Trial Data at ESMO 2025

    13 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/13/3165267/0/en/HUTCHMED-Highlights-FRUSICA-2-Registration-Trial-Data-to-be-Presented-at-the-2025-ESMO-Congress.html

    GLOBENEWSWIRE
    13 Oct 2025
    Share Share
    Sandoz’s Generics Axitinib Receives Tentative Approval In US
    Sandoz’s Generics Axitinib Receives Tentative Approval In US

    07 Oct 2025

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=219705

    FDA
    07 Oct 2025
    Share Share
    Glenmark’s Generics Axitinib Receives Tentative Approval in US
    Glenmark’s Generics Axitinib Receives Tentative Approval in US

    21 Jul 2025

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213235

    FDA
    21 Jul 2025
    Share Share
    Ocular Therapeutix Accelerated Timelines For SOL-1 Trial In Wet AMD
    Ocular Therapeutix Accelerated Timelines For SOL-1 Trial In Wet AMD

    15 Oct 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/10/15/2963077/0/en/Ocular-Therapeutix-Announces-Accelerated-Timelines-for-SOL-1-Registrational-Trial-of-AXPAXLI-in-Wet-AMD.html

    GLOBENEWSWIRE
    15 Oct 2024
    Share Share
    Clearside's CLS-AX excels in phase 2b trial, set for phase 3
    Clearside's CLS-AX excels in phase 2b trial, set for phase 3

    10 Oct 2024

    // FIERCE PHARMA

    https://www.fiercepharma.com/pharma/clearside-eye-disease-candidate-aces-exam-pursuit-roches-vabysmo-and-regeneron-and-bayers

    FIERCE PHARMA
    10 Oct 2024
    Share Share
    Ocular Therapeutix To Present At UBS Ophthalmology Day 2024
    Ocular Therapeutix To Present At UBS Ophthalmology Day 2024

    25 Sep 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/09/25/2952853/0/en/Ocular-Therapeutix-to-Present-at-the-UBS-Virtual-Ophthalmology-Day-2024.html

    GLOBENEWSWIRE
    25 Sep 2024
    Share Share